INSYS Therapeutics COO Daniel Brennan receives $5.4M in 2015
INSYS Therapeutics reports 2015 executive compensation
By ExecPay News
Published: April 17, 2017
INSYS Therapeutics reported fiscal year 2015 executive compensation information on April 17, 2017.
In 2015, five executives at INSYS Therapeutics received on average a compensation package of $2.5M, a 15% increase compared to previous year.
Average pay of disclosed executives at INSYS Therapeutics
Daniel Brennan, Chief Operating Officer, received $5.4M in total. 90% of Brennan's compensation, or $4.8M, was in option awards. Brennan also received $250K in bonus, $47K in salary, $250K in stock awards, as well as $2K in other compensation.
Michael L. Babich, Chief Executive Officer, received a compensation package of $3.9M, which increased by 52% compared to previous year. 77% of the compensation package, or $3M, was in option awards.
Darryl S. Baker, Chief Financial Officer, earned $1.3M in 2015, a 8% increase compared to previous year.
Franc Del Fosse, General Counsel, received $1.3M in 2015, which decreases by 52% compared to 2014.
John N. Kapoor, Chief Executive Officer, earned $563K in 2015.
Related executives
You may also like
Source: SEC filing on April 17, 2017.